Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / OrganismsTools
SugarDrawer
GlycanBuilder
Glycan Converters
GlycoMaple
GlycomeAtlas
LM-GlycomeAtlas
GALAXY
MCAW
GlycoSim
GRable
Guidelines
MIRAGE
G90387AM
Summary
- GlyTouCan ID
-
G90387AM
- IUPAC Condensed
- Neu5Ac(a2-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(?1-
- Motifs
- 3-Sialyl-LN (type 2) Lewis x Lex SSEA-1
- Subsumption Level
- Linkage-defined saccharide
- Monoisotopic Mass
- 820.3
3D Structures
GlycoShape
Organisms
| Organisms | Evidence |
|---|---|
| Homo sapiens (human) |
Taxonomic Hierarchy
Pathway
| Pathway Name | Organism |
|---|---|
| Lewis blood group biosynthesis | Rattus norvegicus |
| Lewis blood group biosynthesis | Sus scrofa |
| Lewis blood group biosynthesis | Canis familiaris |
| Lewis blood group biosynthesis | Drosophila melanogaster |
| Lewis blood group biosynthesis | Bos taurus |
| Lewis blood group biosynthesis | Mus musculus |
| Lewis blood group biosynthesis | Caenorhabditis elegans |
| Lewis blood group biosynthesis | Homo sapiens |
| Lewis blood group biosynthesis | Xenopus tropicalis |
| Lewis blood group biosynthesis | Gallus gallus |
Sequence Descriptors
- GlycoCT
-
RES 1b:x-dglc-HEX-1:5 2s:n-acetyl 3b:a-lgal-HEX-1:5|6:d 4b:b-dgal-HEX-1:5 5b:a-dgro-dgal-NON-2:6|1:a|2:keto|3:d 6s:n-acetyl LIN 1:1d(2+1)2n 2:1o(3+1)3d 3:1o(4+1)4d 4:4o(3+2)5d 5:5d(5+1)6n
- WURCS
- WURCS=2.0/4,4,3/[a2122h-1x_1-5_2*NCC/3=O][a1221m-1a_1-5][a2112h-1b_1-5][Aad21122h-2a_2-6_5*NCC/3=O]/1-2-3-4/a3-b1_a4-c1_c3-d2
Literature
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 38197965 | Altered expression of Sialyl Lewis X in experimental models of Parkinson’s disease | Nunes MJ | 2024 Jan 10 |
|
| 38387051 | Prevention of experimental autoimmune encephalomyelitis by targeting 6-sulfo sialyl Lewis X glycans involved in lymphocyte homing | Liu Q | 2024 Feb 22 |
|
| 38340724 | Merkel cell polyomavirus-specific and CD39+CLA+ CD8 T cells as blood-based predictive biomarkers for PD-1 blockade in Merkel cell carcinoma | Ryu H | 2024 Feb 20 |
|
| 38064497 | Prevention of Collagen-Induced Arthritis by an Anti-Glycan Monoclonal Antibody Reactive with 6-Sulfo Sialyl Lewis x in DBA/1 Mice | Wei Z | 2024 Feb 01 |
|
| 38348177 | Precision USPIO-PEG-SLex Nanotheranostic Agent Targeted Photothermal Therapy for Enhanced Anti-PD-L1 Immunotherapy to Treat Immunotherapy Resistance | Li T | 2024 Feb |
|
| 38659295 | Combining 5‐azacitidine with the E‐selectin antagonist uproleselan is an effective strategy to augment responses in myelodysplasia and acute myeloid leukaemia | Enjeti AK | 2024 Apr 24 |
|
| 38639586 | Sialyl Lewis X Defines an Activated and Functional Regulatory T Cell Subpopulation in Mice | Ohishi K | 2024 Apr 19 |
|
| 38578028 | Let's Get Rolling: Precise Control of Microfluidic Assay Conditions to Recapitulate Selectin‐Mediated Rolling Interactions of the Leukocyte Adhesion Cascade | Amoabediny Z | 2024 Apr |
|
| 37735247 | A novel monoclonal antibody against 6-sulfo sialyl Lewis x glycans attenuates murine allergic rhinitis by suppressing Th2 immune responses | Liu W | 2023 Sep 21 |
|
| 36985569 | A Structural-Reporter Group to Determine the Core Conformation of Sialyl Lewisx Mimetics | Wagner B | 2023 Mar 13 |
|
